In other retinal disorders like glaucoma or DR, minocycline also inhibits the release of the pro-inflammatory cytokines IL-1β, and TNF-α, the expression of PARP1, and photoreceptor cell death [102,103,104]. This evidence concerns the gene TNF and glaucoma.